Compression Device Assists Hemostasis of the Radial Artery

An innovative device compresses the access site following transradial procedures, maintaining hemostasis while keeping it visible for clinical monitoring.

The Maquet Air-Band Radial Compression Device is a 26-cm long, latex-free, self-adhesive wristband with a clear window and bulb that facilitates visualization of the puncture site. A Luer valve at the end of the clear-fill tube enables any standard syringe to be connected, allowing inflation and deflation of the bulb with air to provide compression of the radial puncture site. The textile wristband of the device contributes to patient comfort, while the surface adhesive enables a secure fit around all patient wrists, avoiding movement and dislocation.


The device simplifies hemostasis management by delivering hands-free adjustable pressure and by offering simple application and removal. In addition, both the size and shape of the Air-Band inflatable bulb minimizes the compression risk to surrounding nerve structures or areas other than the radial puncture site. The Maquet Air-Band Radial Compression Device is a product of MAQUET (Rastatt, Germany), and has been approved by the US Food and Drug Administration (FDA), and received the European Union CE marking of approval.

“We have found that Air-Band is easy to use, reliable and effective in achieving hemostasis following radially accessed coronary catheterization procedures,” said interventional cardiologist Christian Valina, MD, of the University Heart Center of Bad Krozingen (Germany). “My colleagues and I were impressed by the secure fit around the wrist that the adhesive band provides. We believe that Air-Band represents important progress towards ensuring patient safety and comfort during these important procedures.”

“Drawing on our significant experience in hemostasis management, we designed Air-Band to provide all the valued benefits of our safeguard pressure assisted device, which assists in obtaining and maintaining hemostasis after a femoral procedure, and applied our knowledge to a radial application,” said Christian Keller, president and CEO of MAQUET Cardiovascular.

Related Links:
MAQUET